FDA warns against high-lidocaine OTC topical pain relief products for cosmetic procedures, cites violations by six companies.

The FDA has warned consumers to avoid using certain over-the-counter topical pain relief products containing high concentrations of lidocaine, marketed to relieve pain before, during, or after specific cosmetic procedures like microdermabrasion, laser hair removal, tattooing, and piercing. The FDA has issued warning letters to six companies for violating federal laws by marketing unapproved, misbranded products with higher-than-allowed concentrations of lidocaine. These products pose unacceptable risks to consumers and should not be on the market, according to the FDA.

March 27, 2024
19 Articles

Further Reading